Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Goes It Alone ... for Now
Motley Fool
Thursday, January 7, 2010 - 9:55am
tags:
Gilead Sciences, HIV, Quad
Lundbeck Faces EU Antitrust Probe Into Generic Sales
Bloomberg
Thursday, January 7, 2010 - 9:54am
tags:
Lundbeck, antitrust, generics, antidepressants, Europe
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Bloomberg
Thursday, January 7, 2010 - 9:52am
tags:
FDA, anemia, Amgen, Aranesp, Epogen, Procrit, JNJ
MannKind shares gain ground ahead of FDA decision
Yahoo/AP
Thursday, January 7, 2010 - 9:51am
tags:
FDA, MannKind, inhaled insulin, Afresa
What Merck’s CEO Said Today About Possible Job Cuts
WSJ Online
Wednesday, January 6, 2010 - 4:04pm
tags:
Merck, Pharma CEOs, layoffs, reorganization, Richard Clark
Still Fixing Pfizer
CNBC
Wednesday, January 6, 2010 - 4:03pm
tags:
Pfizer, Jeff Kindler
Glaxo restructures HR with job, cost cuts
Fierce Pharma
Wednesday, January 6, 2010 - 11:24am
tags:
GSK, restructuring
Vultures Descend and Phoenixes Rise in the Wake of Biotech Consolidation
BNET Pharma
Wednesday, January 6, 2010 - 11:23am
tags:
consolidation, M&A, biotech
Daiichi Sankyo' Subsidiary Acquires PharmaForce
Pharmaceutical Business Review
Wednesday, January 6, 2010 - 11:12am
tags:
PharmaForce, Daiichi Sankyo, M&A, Luitpold
Drug stocks inch up; Gilead gains on HIV study
Marketwatch
Wednesday, January 6, 2010 - 11:06am
tags:
drug stocks, HIV, Gilead Sciences
Pfizer and Strides Arcolab to Collaborate on Generic Products
Yahoo
Wednesday, January 6, 2010 - 10:49am
tags:
generics, Pfizer, Strides Arcolab, partnerships
Celgene's 2010 Guidance Key Event Next Week
TheStreet.com
Wednesday, January 6, 2010 - 10:48am
tags:
Celgene, guidance
Which Drugs Have The Biggest Pre-Tax Margins?
Pharmalot
Wednesday, January 6, 2010 - 10:46am
tags:
Pfizer, AstraZeneca, Novartis, Eli Lilly, Roche, Sanofi, Bristol-Myers Squibb
‘Salami Slicing’ Promoted Lilly’s Cymbalta: Study
Pharmalot
Wednesday, January 6, 2010 - 10:44am
tags:
Cymbalta, Eli Lilly, antidepressants
The Real Reason for Lilly's R&D Outsourcing
Seeking Alpha
Wednesday, January 6, 2010 - 10:43am
tags:
R&D, Eli Lilly, outsourcing
Gilead's HIV Pill Works in Mid-Stage Study
TheStreet.com
Wednesday, January 6, 2010 - 10:42am
tags:
HIV, Gilead Sciences, Quad
Biotech drug approvals spiked in 2009
Fierce Biotech
Wednesday, January 6, 2010 - 8:43am
tags:
biotech, Eli Lilly, Effient, Daiichi Sankyo, denosumab, Amgen, Aventis, Multaq
Vasella’s Persistence Pays Off as Novartis Gains Alcon’s Growth
Bloomberg
Wednesday, January 6, 2010 - 8:42am
tags:
Novartis, Pharma CEOs, Daniel Vasella, Alcon, M&A
FDA cancels meeting to review Lilly's Cymbalta
Yahoo/AP
Wednesday, January 6, 2010 - 7:06am
tags:
FDA, Cymbalta, Eli Lilly, chronic pain
Aryx gets FDA guidance on blood clot drug that failed trial
Bizjournals.com
Wednesday, January 6, 2010 - 7:04am
tags:
anti-clotting, ARYx, FDA, tecarfarin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.